IT

Italy

25897 clinical trials

Find Trials

Clinical Trials (25897)

Showing 20 of 25,897 trialsScroll for more
NCT06072781Phase 312 sites

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Recruiting
NCT07088926Phase 27 sites

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Recruiting

Diagnostic Accuracy of a Deep Learning-Based Software for Automated Multiparametric Echocardiographic Measurements

Recruiting
NCT05217446Phase 212 sites

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Active Not Recruiting
NCT06608927Phase 311 sites

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Active Not Recruiting
NCT06102590Not Applicable3 sites

Oxygen Extraction-guided Transfusion

Recruiting
NCT07196722Phase 29 sites

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Recruiting
NCT05327114Phase 29 sites

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Recruiting
NCT07497087Phase 38 sites

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Recruiting
NCT03888105Phase 210 sites

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Active Not Recruiting
NCT06425991Phase 16 sites

A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Active Not Recruiting
NCT02960022Phase 28 sites

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Recruiting
NCT04770779Phase 38 sites

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Active Not Recruiting
NCT05876754Phase 311 sites

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Active Not Recruiting
NCT06863272Phase 15 sites

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Recruiting
NCT07005154Phase 24 sites

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Recruiting
NCT06662786Phase 35 sites

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Recruiting
NCT04175600Phase 36 sites

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Active Not Recruiting
NCT05889182Phase 39 sites

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Recruiting
NCT05388669Phase 39 sites

A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

Active Not Recruiting